CMS Extends Non-Coverage Policy To All Artificial Lumbar Discs
This article was originally published in The Gray Sheet
Executive Summary
CMS is proposing to extend its national non-coverage policy for Johnson & Johnson/DePuy's Charité to all current and future artificial lumbar discs
You may also be interested in...
Reimbursement Is More Than Passing Thought For Spine Firm In FDA Trials
Non-fusion spinal implant maker Paradigm Spine decided to spend 15%-20% more than needed to satisfy FDA's data requirements in an ongoing pivotal trial for what the company hopes will be its first product on the U.S. market
Reimbursement Is More Than Passing Thought For Spine Firm In FDA Trials
Non-fusion spinal implant maker Paradigm Spine decided to spend 15%-20% more than needed to satisfy FDA's data requirements in an ongoing pivotal trial for what the company hopes will be its first product on the U.S. market
CMS Denies Artificial Lumbar Disc Coverage For Patients Aged 60 And Over
CMS is extending its national non-coverage policy for Johnson & Johnson/DePuy's Charité artificial lumbar disc to Synthes' ProDisc and all future products in that category for Medicare patients over age 60